Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Applied BioSystems To Test Avian Flu Detection Systems Worldwide

This article was originally published in The Pink Sheet Daily

Executive Summary

With trials currently underway in Hong Kong, firm prepares to ship the test around the globe. Applied BioSystems says it could pursue a diagnostic for clinical use with Celera Genomics, but that its aspirations are currently set on offering a tool for global surveillance.

You may also be interested in...



Cosmetic Ingredient Review Finalizes 2021 Priorities; Data Requested

CIR’s 2021 priorities list is heavy with skin-care ingredients and builds on recent natural ingredient review work. The group encourages stakeholders to submit data as soon as possible to help inform its development of scientific literature reviews.

Washington State Ecology Mulls ‘Safer’ Definition While Exploring Phthalate Alternatives In Fragrances

Marissa Smith, senior regulatory toxicologist in the Washington Department of Ecology’s Hazardous Waste and Toxics Reduction program, discusses what’s next for the state’s inaugural Safer Products go-round. “How we define ‘safer’ is really going to be the lynchpin of this whole process,” she says.

CBD Sheet Mask Brand Fails To Sway NAD: We Only Claimed It ‘May’ Have Benefits

The National Advertising Division has notified the US Federal Trade Commission of claims seen at Bloomingdales.com for one of Mask, LLC’s CBD-infused sheet masks, including the product’s name, which implies unsupported acne treatment benefits, according to the NAD.

Topics

UsernamePublicRestriction

Register

ID1132090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel